Tuesday, May 1, 2018

FDA hits Mexican drugmaker Degasa with warning letter

The FDA issued a warning letter to Mexican finished-pharmaceutical manufacturer Degasa for issues including misbranding, failing to conduct adequate testing and problems with its water system.
Post a Comment